Univest
Univest
  • Markets

Sudarshan Pharma Industries Ltd. Hits Lower Circuit on BSE, 8 October 2026

  • September 9, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
Sudarshan Pharma Industries Ltd. Hits Lower Circuit on BSE, 8 October 2026

On 8 October 2026, Sudarshan Pharma Industries Ltd. (SUDARSHAN) hit the lower circuit on BSE at Rs 35.02, a 10% negative move from the previous close of Rs 38.91. The company’s market cap stood at Rs 990.15 crore. The lower circuit price for the session was Rs 35.02.

The Sudarshan Pharma Industries lower circuit came as selling pressure met the exchange-defined price band. At the time of writing the stock was locked at its lower circuit level, which makes the session worth noting for short-term market participants.

Table of Contents

Toggle
  • Key Takeaways
  • Key Market Data
  • Price Action and Trading Activity
  • Why Sudarshan Pharma Industries Ltd. Hit Lower Circuit
  • What the Sudarshan Pharma Industries Lower Circuit Means
  • Sudarshan Pharma Industries Ltd. Fundamentals and Valuation
  • Peer and Sector Context
  • Technical Snapshot
  • What Readers Should Know
  • Frequently Asked Questions
    • Why did Sudarshan Pharma Industries Ltd. hit lower circuit on 8 October 2026?
    • What was SUDARSHAN share price on 8 October 2026?
    • What was the lower circuit price for SUDARSHAN?
    • What is Sudarshan Pharma Industries Ltd.’s market cap and PE ratio?
    • Which exchange and data source were used?
    • Does hitting a lower circuit mean Sudarshan Pharma Industries Ltd. is a buy or a sell?
    • Can you buy or sell Sudarshan Pharma Industries Ltd. shares when the stock is at the lower circuit?
    • What happens the next trading session after a lower circuit?
    • What is the lower circuit limit set at for Indian stocks?

Key Takeaways

  • Sudarshan Pharma Industries Ltd. (SUDARSHAN) hit the lower circuit on BSE at Rs 35.02 on 8 October 2026.
  • The session move was -10% against a previous close of Rs 38.91.
  • Market capitalisation stood at Rs 990.15 crore with a PE ratio of 39.41.
  • No official company announcement or verified catalyst was confirmed at the time of writing.
  • A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric Value
Stock Sudarshan Pharma Industries Ltd.
Current Price / LTP Rs 35.02
Day Move -10%
Previous Close Rs 38.91
Day Open Rs 39
Day High Rs 39
Day Low Rs 35.02
Lower Circuit Price Rs 35.02
Lower Circuit Limit Rs 35.02
Market Cap Rs 990.15 crore
Selected Exchange BSE
PE Ratio 39.41

All figures above are as of 8 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Sudarshan Pharma Industries Ltd. opened at Rs 39 on BSE, compared with a previous close of Rs 38.91. During the session, the stock traded between Rs 35.02 and Rs 39 before touching the lower circuit price of Rs 35.02.

The absolute day change was Rs 3.89, while the percentage move was -10%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated lower circuit limit for the session was Rs 35.02, which is the level the price reached.

Why Sudarshan Pharma Industries Ltd. Hit Lower Circuit

Sudarshan Pharma Industries Ltd. hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the lower circuit level of Rs 35.02.

What the Sudarshan Pharma Industries Lower Circuit Means

A lower circuit is the minimum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Sudarshan Pharma Industries Ltd., the captured lower circuit price was Rs 35.02 on 8 October 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the lower circuit explains what happened in the session and where the price band was reached.

Sudarshan Pharma Industries Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Sudarshan Pharma Industries Ltd., PE ratio was 39.41, PB ratio was 3.02, book value was Rs 12.89, EPS was 0.99, ROE was 13.33%, ROCE was 14.42% and dividend yield was 0%, on a market cap of Rs 990.15 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 3.02, the market valued Sudarshan Pharma Industries Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Sudarshan Pharma Industries Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company Market Cap PE PB ROE
Advanced Enzyme Technologies Ltd. Rs 3024.48 crore 18.23 1.82 11.43%
Hikal Ltd. Rs 2773.03 crore – 2.33 -3.97%
Fredun Pharmaceuticals Ltd. Rs 2521.4 crore 57.54 8.27 16.09%
Dishman Carbogen Amcis Ltd. Rs 2391.73 crore 148 0.36 1.56%
Syncom Formulations (India) Ltd. Rs 2345.3 crore 27.42 5.33 20.19%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Sudarshan Pharma Industries Ltd.’s PE ratio was 39.41, compared with an available peer PE average of 62.8, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Want to know more? Log in to Univest for more stock insights.

Technical Snapshot

The technical snapshot adds context: RSI was 41.71, the 50-day moving average was 39.1 and the 200-day moving average was 34.87.

What Readers Should Know

The main confirmed fact is that Sudarshan Pharma Industries Ltd. hit the lower circuit on BSE at Rs 35.02 on 8 October 2026, with a -10% day move.

The practical limitation after a lower-circuit session is execution. Sellers queue at the band with few buyers, so exiting at the quoted price may not be possible. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat lower circuit events as market updates, not standalone investment conclusions. The price band shows heavy near-term selling pressure, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did Sudarshan Pharma Industries Ltd. hit lower circuit on 8 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was SUDARSHAN share price on 8 October 2026?

The last traded price used in this article was Rs 35.02 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for SUDARSHAN?

The lower circuit price was Rs 35.02. The stated exchange lower circuit limit was Rs 35.02. The event numbers in this article are aligned to BSE.

What is Sudarshan Pharma Industries Ltd.’s market cap and PE ratio?

Sudarshan Pharma Industries Ltd.’s market cap was Rs 990.15 crore. PE ratio was 39.41.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 8 October 2026.

Does hitting a lower circuit mean Sudarshan Pharma Industries Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Sudarshan Pharma Industries Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Sudarshan Pharma Industries Ltd. the stated limit was Rs 35.02. For this session, Sudarshan Pharma Industries Ltd. moved -10%.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply